Navigation Links
BioMS Medical Announces Second Quarter 2008 Results
Date:8/12/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, Aug. 12 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the second quarter ended June 30, 2008. BioMS Medical, in partnership with Eli Lilly and Company (Lilly), is developing MBP8298 (dirucotide), a drug for the treatment of MS undergoing pivotal trials in Canada, Europe and the US.

"The three randomized late-stage clinical trials for MBP8298 (dirucotide) continue to progress very well. We recently announced that MAESTRO-03, our U.S. phase III secondary progressive MS trial, was fully recruited with approximately 510 patients," said Kevin Giese, President and CEO of BioMS Medical. "During the quarter, BioMS was also honored to receive the Gold Leaf Award from BIOTECanada in recognition of our selection as "Company of the Year".

Currently, BioMS is conducting three clinical trials and one open-label follow-on trial for MBP8298 (dirucotide):

(x) MAESTRO-01: A randomized, double-blind pivotal phase II/III trial in Canada and Europe evaluating MBP8298 (dirucotide) for the treatment of secondary progressive MS (SPMS). The study has completed full recruitment of 611 patients at 47 trial sites in 10 countries. Patients are administered either MBP8298 (dirucotide) or placebo every six months for a period of two years. To date, there have been eight positive safety reviews from the Data Safety Monitoring Board (DSMB).

(x) MAESTRO-02: An open-label follow-on study to the MAESTRO-01 pivotal trial. Eligible patients who have successfully completed the blinded, placebo controlled MAESTRO-01 trial may choose to receive MBP8298 (dirucotide) on an un-blinded basis. To date, approximately 95% of patients enrolled in MAESTRO-01 have proceeded to MAESTRO-02.

(x) MAESTRO-03: A U.S. pivotal phase III trial evaluating MBP8298 (dirucotide) for the treatme
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medical to present at BIO CEO & Investor Conference
10. BioMS Medical Announces 2007 Year End Results
11. BioMS Medical to present at BioCentury Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...dPredict Market Research, a,global provider of ph...research, has published a new report providing cri...mpanies with a stake in the market for Parkinson,s...hought Leader Insight &,Analysis -- Parkinson...h PD,experts from the US (6) and Europe (3). , ...
(Date:12/2/2008)...Call/ -- Bionovo, Inc.,(Nasdaq: BNVI ), a pharm...velopment of safe and effective drugs in the areas...ac Cohen, Chairman and CEO of Bionovo, will be,pr...nual Piper Jaffray Health,Care Conference at 8 a....d at,the New York Palace Hotel in New York City. ...
(Date:12/2/2008)...-- eResearchTechnology, Inc.,(eRT), (Nasdaq: ER...linical,technology, ePRO and other services to th...nd related industries, announced today that Dr. Mi...ief Executive Officer, and Keith,Schneck, the Com...resent at,the Piper Jaffray Health Care Conferenc...
(Date:12/2/2008)...Sciences has turned to MBI International to join t...ity of an important bio-based product line. MBI In...n research and commercialization through collabora...uo;s unique “Collaborative De-Risking”...certainties, which impede new technologies from ge...
Breaking Biology Technology:New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinson's Disease Drug Development 2Bionovo to Present at the Piper Jaffray Healthcare Conference 2eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008 2 DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product 2
..., , , , , , PLG can be used i...e lysis , procedure.(1,2,3), The ba...s grown for 1214 , hours in up to 500 ml ... , ml Terrific Broth. , , ...0,000 x g for 5 minutes at room , tempe...
...trations with the Perfect gDNA Blood Mini Kit ,... , , , , , , Laura Polloc...ime, Boulder, Colorado, , , , , ...Perfect gDNA Blood Mini Kit protocol recommends ,...tal yield in standard , application. In s...
... , , , , , , This method pr..., g lgt10 DNA per 450 l of supernatant proc...unction with other LambdaDNA purification methods.... stock of suitable plating bacteria in L-broth plu...ct, 0.5% NaCl, 1 mM MgSO4, pH 7.5) overnight , ...
..., , , , Katherine A. Borkovich Ph...ovich PhD, University of Texas-Houston Medical Cen...Molecular Genetics, Houston, Texas. , Kimb...oSystems Application , Lab, Westbury, New Y...CTION: , The diverse reproductive capabi...
Other Biology Technology:Basic Plasmid DNA Isolation Protocol 2Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 2Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 3Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 4Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 5Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 6Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit , by Varying the Final Elution Volume 7Lambda DNA Extraction Protocol 2Efficient Transfection of Neurospora Crassa 2Efficient Transfection of Neurospora Crassa 3Efficient Transfection of Neurospora Crassa 4Efficient Transfection of Neurospora Crassa 5
(Date:12/1/2008)...ow marine animals find their way back to their bir...nds of miles of open ocean has mystified scientist...t the University of North Carolina at Chapel Hill .... , At the beginning of their lives, salmon and ...ome area and "imprint" on it, according to a new t...
(Date:12/1/2008)...pital Projecta collaboration of Stanford Universit...e Conservancy and the World Wildlife Fundhas been ...ordon and Betty Moore Foundation to develop a soft...ic benefits provided by temperate marine ecosystem...of Ecosystem Services and Tradeoffs), the proposed...
(Date:12/1/2008)...ilable at the online site of the journal Biology ...ts for the first time that vitamin D induces immun...oduction of the antimicrobial protein cathelicidin...rophoblast cells to the active form of vitamin D, ...ased antibacterial response in the trophoblast cel...
(Date:12/1/2008)...R.I. [Brown University] Gray mold is a gardener,s...ic name Botrytis cinerea , is a scourge to more t... including staples such as tomatoes, strawberries,... peas, peppers, and potatoes. Gray mold envelops i...t poisons the host plants, cells, eventually causi...
Breaking Biology News(10 mins):No place like home: New theory for how salmon, sea turtles find their birthplace 2No place like home: New theory for how salmon, sea turtles find their birthplace 3Natural Capital Project to develop conservation software 2Brown chemist finds gray mold's killer gene 2 244 million nursing grant focuses on at risk premature infants 2948 1 244 million nursing grant focuses on at risk premature infants 2948 2US launch of international consultation for new responsible nanocode 685 1US launch of international consultation for new responsible nanocode 685 2General Wesley K Clark 28Ret 29 to Address Home Care Professionals 2942 1General Wesley K Clark 28Ret 29 to Address Home Care Professionals 2942 2General Wesley K Clark 28Ret 29 to Address Home Care Professionals 2942 3PA Governor Rendell Announces Latest Nominations and Appointments 2938 1PA Governor Rendell Announces Latest Nominations and Appointments 2938 2PA Governor Rendell Announces Latest Nominations and Appointments 2938 3
...al focus on protecting Earth,s ecosystems across ...ing to a new book released today by CEMEX, Conserv..., "Transboundary Conservation: A New Vision for Pr... of shared environmental responsibility for keepin...ational borders. , Stunningly illustrated, the b...
...with the flatworm, planaria, offers new clues for ...archers at The Forsyth Institute have discovered h...r and regenerate tissue. Forsyth scientists have ...tly linking neighboring cells) communication contr.... Michael Levin, underlies principles that can pot...
...a new computerized system to easilymonitor the lev...vecare. , A study published today in the open acce...ing reports that GRIP, a computersoftware that ass...lly ill patients, saves nurses time and effort and...ently used in manyintensive care units (ICUs). Mon...
... when, your nervous system must coordinate a laund...mation about energy level, food preferences, and m...ation about the quality of available food, determi...the fruitfly Drosophila have traced the path of ol...in the mouth, which set off neurons that signal th...
Other Biology News:New book highlights world's borderless conservation areas 2New understanding of regeneration gained by Forsyth scientists 2How Fruitflies Know It's Time for Lunch 2How Fruitflies Know It's Time for Lunch 3
Shotgun library construction and high-throughput DNA sequencing of microbial genomes, BACs, adenoviruses, phosmids and cosmids. LIMS tracking utilizing Geospiza's Finch system.
... (amino terminus) XAB2 (XPA-binding protein 2) wa...A. Immunoprecipitation experiments have also demon... transcription-coupled repair-specific proteins CS...injection experiments with XAB2 antibodies resulte...
Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
A component of the Acridinium protein labeling kit.
Biology Products: